SARCLISA 20MG/ML INF CNC SOL 1X25ML

Rychlý přehled

Dosage form Solution concentrate infusion
Výdej Ne, lék nelze získat bez receptu.
Úhrada / doplatek / cena Lék, jehož použití je s ohledem na veřejný zájem účelné koncentrovat do specializovaných pracovišť dle § 15 odst. 10 zákona o veřejném zdravotním pojištění. Lék je hrazen jako ZÚLP a to pouze z pracoviště, které má smlouvu se zdravotní poj…
Kdo může předepsat Prescription is not conditional on a medical specialization.
Složení Izatuximab (20 mg), sacharosa, monohydrát histidin-hydrochloridu, histidin, polysorbát 80, voda pro injekci (1 ml). More information about the composition can be found in the SPC, section 6.1.
Dostupnost / výpadek Obnoveno The latest report from the manufacturer is from 6. 5. 2024. Výroba je obnovena od 3. 5. 2024.
Kód SÚKL 0249553

What is the maximum co-payment for SARCLISA?

If the insurance company contributes, the maximum co-payment is 5 690,00 Kč. The maximum pharmacy price is 54 240,15 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price. If the physician marks increased reimbursement on the prescription, the maximum co-payment is 4 337,15 Kč.

Does the medicine have reimbursement from public health insurance?

A medicine whose use is, in the public interest, appropriate to concentrate in specialized facilities pursuant to Section 15(10) of the Public Health Insurance Act. The medicine is reimbursed as ZÚLP and only from a facility that has a contract with the health insurer.

Does SARCLISA have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

48 550,15 Kč.

Does the insurance company pay a higher amount in some cases?

Yes, increased reimbursement exists. A physician with the required specialization may, under strictly defined conditions, set a second reimbursement of 49 903,00 Kč.

Does the medicine have an indication restriction?

Isatuximab je hrazen v kombinaci s bortezomibem, lenalidomidem a dexamethasonem k léčbě dospělých pacientů s nově diagnostikovaným mnohočetným myelomem, kteří splňují všechny následující podmínky:
a) jsou nevhodní pro transplantaci kostní dřeně,
b) mají stav výkonnosti dle ECOG 0-2.
Terapie isatuximabem je hrazena do progrese onemocnění dle platných kritérií IMWG (Mezinárodní pracovní skupiny pro myelom) nebo do projevů nepřijatelné toxicity. V případě nutnosti přerušení či ukončení terapie jednou z ostatních složek režimu je možné pokračovat v léčbě zbylými složkami režimu.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe SARCLISA?

Prescription is not conditional on a medical specialization.

What is the composition of SARCLISA?

Izatuximab (20 mg), sacharosa, monohydrát histidin-hydrochloridu, histidin, polysorbát 80, voda pro injekci (1 ml). More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to SARCLISA?

The medicine belongs to ATC group L01FC02 – . Medicines with the same active substance can be found here.

Who manufactures SARCLISA?

Informace o výrobci není dostupná.

Is the medicine in shortage?

The latest report from the manufacturer is from 6. 5. 2024. Production has been resumed as of 3. 5. 2024.

What is the unique code for SARCLISA?

The medicine has code 0249553. Code details can be found here.

How many packs of SARCLISA were previously dispensed on prescriptions in Czechia?

Show prescription medicine consumption

How many packs of SARCLISA were previously dispensed on request forms in Czechia?

Show request-form medicine consumption

Z čeho se skládá maximální cena léku?

The page was last updated on 17. 07. 2026

SIMILAR MEDICINES: